Investigation of Alleged Wrongdoing by Management and Board of Directors of Fluence Energy, Inc., Kyverna Therapeutics, Inc., Mercury Systems, Inc., and Sage Therapeutics, Inc.

Fulcrum Energy, Kyverna Therapeutics Notice Shareholders

March 25, 2023 - Fulcrum Energy, Inc. (NASDAQ: FLNC) and Kyverna Therapeutics, Inc. (NASDAQ: KVTX) have issued a joint notice to long-term shareholders. The companies have been working together to complete the previously announced merger, and the notice serves as a reminder of the upcoming deadline.

The merger, which was announced in January, is expected to create a leading biotechnology company focused on developing innovative therapies for various diseases. The combined entity will have a strong pipeline of products and a robust financial foundation to support future growth.

As part of the merger, long-term shareholders of both companies are encouraged to take action by the deadline to ensure they receive the appropriate shares in the combined company. The notice provides detailed information on the merger process, including the exchange ratio and the procedures for submitting claims.

The companies have also emphasized the importance of this merger, stating that it will create a unique opportunity for long-term shareholders to benefit from the combined entity's strengths and capabilities.

The deadline for submitting claims is April 15, 2023. Shareholders who fail to take action by this date may forfeit their rights to receive shares in the combined company. The companies encourage all eligible shareholders to review the notice and take the necessary steps to ensure their participation in the merger.

The merger is expected to close in the second quarter of 2023, subject to regulatory approvals and other customary conditions. Further updates will be provided as the process unfolds.